{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:22:25Z","timestamp":1740122545613,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["16-0020"],"award-info":[{"award-number":["16-0020"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11239-019-01910-0","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T09:03:12Z","timestamp":1561971792000},"page":"619-622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement?"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5561-2560","authenticated-orcid":false,"given":"Matej","family":"Samo\u0161","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Bolek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"\u0160kor\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Benko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1n","family":"Sta\u0161ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kubisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Galajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00e1n","family":"Mok\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11239-016-1458-9","volume":"43","author":"G Delgado-Garc\u00eda","year":"2017","unstructured":"Delgado-Garc\u00eda G, Monreal-Robles R (2017) Acuteapixaban treatment of heparin-induced thrombocytopenia. J Thromb Thrombolysis 43:289\u2013290","journal-title":"J Thromb Thrombolysis"},{"key":"1910_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-017-0080-7","volume":"6","author":"DE Ezekwudo","year":"2017","unstructured":"Ezekwudo DE, Chacko R, Gbadamosi B, Batool S, Gaikazian S, Warkentin TE, Sheppard JI, Jaiyesimi I (2017) Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature. Exp Hematol Oncol 6:21","journal-title":"Exp Hematol Oncol"},{"key":"1910_CR3","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/ccr3.1817","volume":"6","author":"D Trujillo Agudelo","year":"2018","unstructured":"Trujillo Agudelo D, Ramirez Quintero JD, Arango Barrientos M (2018) Successful treatment of heparin-induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis. Clin Case Rep 6:2147\u20132149","journal-title":"Clin Case Rep"},{"key":"1910_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/clc.22659","volume":"40","author":"RE Owens","year":"2017","unstructured":"Owens RE, Kabra R, Oliphant CS (2017) Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review. Clin Cardiol 40:407\u2013412","journal-title":"Clin Cardiol"},{"key":"1910_CR5","doi-asserted-by":"publisher","first-page":"A2096","DOI":"10.1016\/S0735-1097(14)62099-4","volume":"63","author":"M Sharii","year":"2014","unstructured":"Sharii M, Freeman W, Bay C, Sharii M, Breed C, Schwartz F (2014) Treatment of heparin-induced thrombocytopenia with new oral anticoagulants [abstract]. J Am Coll Cardiol 63:A2096","journal-title":"J Am Coll Cardiol"},{"key":"1910_CR6","first-page":"798","volume":"151","author":"G Delgado-Garc\u00eda","year":"2015","unstructured":"Delgado-Garc\u00eda G, Monreal-Robles R, Gallegos-Arguijo D, Marfil-Rivera J (2015) Apixaban as therapeutic option in nephropathy patients with heparin-induced thrombocytopenia (HIT). Gac Med Mex 151:798\u2013801","journal-title":"Gac Med Mex"},{"key":"1910_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ccr3.411","volume":"3","author":"PB Larsen","year":"2015","unstructured":"Larsen PB, J\u00f8rgensen M, Friis-Hansen L, Ingeberg S (2015) Apixaban used for the management of heparin-induced thrombocytopenia in a 72-year-old woman with lung cancer. Clin Case Rep 3:987\u2013989","journal-title":"Clin Case Rep"},{"key":"1910_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/ejh.12921","volume":"99","author":"KA Davis","year":"2017","unstructured":"Davis KA, Davis DO (2017) Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia. Eur J Haematol 99:332\u2013335","journal-title":"Eur J Haematol"},{"key":"1910_CR9","first-page":"391","volume":"68","author":"M Samo\u0161","year":"2016","unstructured":"Samo\u0161 M, Bolek T, Ivankov\u00e1 J, Stan\u010diakov\u00e1 L, Kov\u00e1\u0159 F, Galajda P, Kubisz P, Sta\u0161ko J, Mok\u00e1\u0148 M (2016) Heparin-induced thrombocytopenia presenting with deep venous thrombosis and pulmonary embolism successfully treated with rivaroxaban: clinical case report and review of current experiences. J CardiovascPharmacol 68:391\u2013394","journal-title":"J CardiovascPharmacol"},{"key":"1910_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jth.14001","volume":"16","author":"S Testa","year":"2018","unstructured":"Testa S, Paoletti O, Legnani C, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G (2018) Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost 16:842\u2013848","journal-title":"J Thromb Haemost"},{"key":"1910_CR11","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/jth.13330","volume":"14","author":"LA Linkins","year":"2016","unstructured":"Linkins LA, Warkentin TE, Pai M, Shivakumar S, Manji RA, Wells PS, Wu C, Nazi I, Crowther MA (2016) Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study. J Thromb Haemost 14:1206\u20131210","journal-title":"J Thromb Haemost"},{"key":"1910_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jcph.1300","volume":"59","author":"S Nasiripour","year":"2019","unstructured":"Nasiripour S, Saif M, Farasatinasab M, Emami S, Amouzegar A, Basi A, Mokhtari M (2019) Dabigatran as a treatment option for heparin-induced thrombocytopenia. J Clin Pharmacol 59:107\u2013111","journal-title":"J Clin Pharmacol"},{"key":"1910_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","volume":"10","author":"J Seeger","year":"2017","unstructured":"Seeger J, Gonska B, Rodewald C, Rottbauer W, W\u00f6hrle J (2017) Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement. JACC Cardiovasc Interv 10:66\u201374","journal-title":"JACC Cardiovasc Interv"},{"key":"1910_CR14","doi-asserted-by":"publisher","first-page":"e005593","DOI":"10.1161\/CIRCINTERVENTIONS.117.005593","volume":"10","author":"N Berry","year":"2017","unstructured":"Berry N, Sawlani N, Kim A, Kaneko T, Shah P, Pelletier M, Sobieszczyk P (2017) Very early subclinical valve thrombosis after transcatheter aortic valve replacement. Circ Cardiovasc Interv 10:e005593","journal-title":"Circ Cardiovasc Interv"},{"key":"1910_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000491077","volume":"140","author":"S Khan","year":"2018","unstructured":"Khan S, Achike O, Nekkanti R, Carabello B (2018) Successful apixaban treatment of TAVR thrombosis after warfarin failure. Cardiology 140:199\u2013203","journal-title":"Cardiology"},{"key":"1910_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","volume":"200","author":"JP Collet","year":"2018","unstructured":"Collet JP, Berti S, Cequier A, Van Belle E, Lefevre T, Leprince P, Neumann FJ, Vicaut E, Montalescot G (2018) Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial. Am Heart J 200:44\u201350","journal-title":"Am Heart J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01910-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01910-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01910-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T23:12:47Z","timestamp":1593472367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01910-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01910-0","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"1 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Matej Samo\u0161, Tom\u00e1\u0161 Bolek, Ingrid \u0160kor\u0148ov\u00e1, Jakub Benko, J\u00e1n Sta\u0161ko, Peter Kubisz, Peter Galajda, and Mari\u00e1nMok\u00e1\u0148 declare that they have no conflicts of interest that might be relevant to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was supported by APVV Project 16-0020 (Slovak Research and Development Agency).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This research was conducted according to ethical standards and was approved by the local ethical committee (Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava). The patient agreed to participate in the research and signed the informed consent for participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and inform consent"}}]}}